Eltrombopag named patient programme for patients with chronic immune thrombocytopenia

Br J Haematol. 2012 Apr;157(2):259-60. doi: 10.1111/j.1365-2141.2011.08954.x. Epub 2011 Nov 17.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Benzoates / administration & dosage*
  • Benzoates / adverse effects
  • Child
  • Child, Preschool
  • Chronic Disease
  • Female
  • Humans
  • Hydrazines / administration & dosage*
  • Hydrazines / adverse effects
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / immunology
  • Pyrazoles / administration & dosage*
  • Pyrazoles / adverse effects

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • eltrombopag